Seasonal influenza market analysis focusing on growth potential and outlook

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Seasonal Influenza Market Compare Between 2026 And 2030?

The seasonal influenza market has expanded considerably over recent years. It is projected to increase from $9.85 billion in 2025 to $11.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.1%. This historical growth can be linked to factors like seasonal flu outbreaks, restricted vaccine coverage, prevalent conventional diagnostics, insufficient public awareness, and obstacles in regional distribution.

The seasonal influenza market is poised for substantial expansion over the next few years. It is forecast to grow to $21.39 billion by 2030, achieving a compound annual growth rate (CAGR) of 16.7%. This growth in the projected period can be ascribed to advancements in universal vaccines, swift point-of-care diagnostic solutions, digital systems for immunization tracking, joint public-private vaccination campaigns, and enhanced supply chain optimization. Significant trends during the forecast period encompass universal flu vaccines, accelerated diagnostic tests, in-home vaccination options, rising government immunization programs, and the modernization of pharmaceutical supply chains.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21285&type=smp

What Key Factors Are Shaping The Seasonal Influenza Market Landscape?

The increasing occurrence of respiratory infections is anticipated to propel the growth of the seasonal influenza market moving forward. Respiratory infections are ailments stemming from viruses or bacteria that impact the respiratory system, encompassing parts like the sinuses, throat, airways, or lungs. This rise in the prevalence of respiratory infections is driven by factors such as air pollution, changing climates, weakened immune responses, and the simple transmission of viruses in congested or inadequately ventilated spaces. Seasonal influenza treatment plays a role in preventing or mitigating the severity of respiratory infections through various mechanisms, primarily by targeting the influenza virus and managing symptoms that could otherwise lead to secondary infections. For instance, in October 2024, data from the UK Health Security Agency, a UK-based government agency, revealed that the number of tuberculosis (TB) (a respiratory infection caused by the bacterium Mycobacterium tuberculosis) cases in England experienced a 10.7% year-over-year increase in 2023, rising from 4,380 cases in 2022 to 4,850 cases. Consequently, the escalating incidence of respiratory infections will drive the expansion of the seasonal influenza market.

Which Segment Types Are Examined In The Seasonal Influenza Market Segment Study?

The seasonal influenza market covered in this report is segmented –

1) By Type: Influenza A Virus, Influenza B Virus, Influenza C Virus, Influenza D Virus

2) By Route Of Administration: Parenteral, Oral, Other Route Of Administrations

3) By Distribution Channel: Hospital, Government And institutional supply, Pharmacy, Online

4) By Treatment: Antiviral, Neuraminidase Inhibitors, Vaccination, Other Treatments

Subsegments:

1) By Influenza A Virus: Subtype H1N1, Subtype H3N2, Other Subtypes

2) By Influenza B Virus: Lineage Victoria, Lineage Yamagata

3) By Influenza C Virus: Seasonal C Virus, Non-seasonal C Virus

4) By Influenza D Virus: Animal-associated Influenza D, Zoonotic Surveillance And Research Applications

What Market Trends Are Affecting The Seasonal Influenza Market?

Major companies within the seasonal influenza market are concentrating on advancements in treatment, particularly combination vaccines, with the aim of boosting immunity by addressing multiple viral strains, thereby enhancing effectiveness and decreasing the necessity for frequent vaccinations. Combination vaccines provide protection against numerous diseases or strains through a single injection, reducing the overall number of shots required for immunization. For example, in October 2023, Moderna, Inc., a US-based biotechnology company, reported positive interim Phase 1/2 trial results for mRNA-1083, its investigational combination vaccine targeting both influenza and COVID-19. Developed to improve compliance, simplify administration, and offer greater convenience for individuals and healthcare systems, mRNA-1083 is currently being evaluated for safety and immunogenicity in comparison to standard flu vaccines Fluarix (for ages 50-64) and Fluzone HD (for ages 65-79), as well as against the Spikevax booster.

Which Players Are Part Of The Competitive Landscape Of The Seasonal Influenza Market?

Major companies operating in the seasonal influenza market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Sanofi S.A., AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc, Merck KGaA, Moderna Inc., Boehringer Ingelheim International GmbH, Sinovac Biotech Ltd., Daiichi Sankyo Company Limited, CSL Limited, Genentech Inc., Shionogi & Co. Ltd., Emergent BioSolutions Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Bharat Biotech International Limited, Vaxart Inc., Inovio Pharmaceuticals Inc., SK bioscience Co. Ltd., Mitsubishi Tanabe Pharma Corporation, FluGen Inc., Altimmune Inc.

Get The Full Seasonal Influenza Market Report:

https://www.thebusinessresearchcompany.com/report/seasonal-influenza-global-market-report

Where Is The Seasonal Influenza Market Primarily Concentrated By Region?

North America was the largest region in the seasonal influenza market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the seasonal influenza market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Seasonal Influenza Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/seasonal-influenza-global-market-report

Browse Through More Reports Similar to the Global Seasonal Influenza Market 2026, By The Business Research Company

Influenza Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Influenza Treatment Market Report

https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

Swine Flu Vaccination Market Report

https://www.thebusinessresearchcompany.com/report/swine-flu-vaccination-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795